• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Imrecoxib Inhibitor

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5754992

Imrecoxib is a novel and selective cyclooxygenase 2 (COX-2) inhibitor (IC50: 18nM). It also inhibits COX1- activity (IC50: 115nM). Imrecoxib has an anti-inflammatory effect. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Imrecoxib, Inhibitor
Full Product Name
Imrecoxib
Product Synonym Names
BAP-909
Form/Format
Solid. Powder
Purity/Purification
98.00%
Preparation and Storage
Store at -20 degree C for 3 years powder
-80 degree C for 2 years in solvent
Molecular Weight
369.48
Solubility
DMSO: 100mg/mL (270.65mM) Need ultrasonic
(<1mg/ml refers to the product slightly soluble or insoluble)
Formula
C21H23NO3S
SMILES
O=C1N(CCC)CC(C2=CC=C(S(=O)(C)=O)C=C2)=C1C3=CC=C(C)C=C3
CAS Number
395683-14-4
Target & IC50
Human COX-1: ic50 115nM
Human COX-2: ic50 18nM
In Vitro
Imrecoxib (gastrointestinal administration; 5-20mg/kg; started on day 7; 26 days) diminishes the secondary paw swelling. It also inhibits heat-inactivated BCG induced-inflammtory polyarthritis. Imrecoxib (gastrointestinal administration; 5-20mg/kg; 1 hour before carrageenan injection) suppresses carrageenan-induced acute inflammation, and the inhibitory effect is maximal at 4 hours[1].

Structure of Imrecoxib, inhibitor

Imrecoxib Inhibitor – Cat# MBS5754992

Product References and Citations for Imrecoxib, inhibitor

Chen XH, et al. Imrecoxib: a novel and selective cyclooxygenase 2 inhibitor with anti-inflammatory effect. Acta Pharmacol Sin. 2004 Jul;25(7):927-31.
Chen XH, et al. Imrecoxib: a novel and selective cyclooxygenase 2 inhibitor with anti-inflammatory effect. Acta Pharmacol Sin. 2004 Jul;25(7):927-31.

Other Notes

Small volumes of Imrecoxib, inhibitor vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Imrecoxib purchase

MBS5754992 is an inhibitor targeting Imrecoxib.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000